Last updated: February 27, 2026
What is the excipient profile of ADVIL LIQUIGELS?
ADVIL LIQUIGELS contain the active ingredient ibuprofen, typically at concentrations of 200 mg per capsule. The formulation includes multiple excipients designed to ensure stability, bioavailability, and consumer acceptance. The excipient composition generally comprises:
- Polyethylene glycol (PEG) 400: improves solubility and absorption.
- Gelatin: forms the capsule shell, providing stability and controlled dissolution.
- Glycerin: acts as a plasticizer in capsule manufacturing.
- Propylene glycol: enhances solubility and stability.
- Water: solvent and stabilizer.
The exact formulation is proprietary, but formulations are consistent with over-the-counter (OTC) liquid-filled capsules targeting rapid absorption.
How do excipients influence the product’s performance?
Excipients like PEG, glycerin, and propylene glycol aid in:
- Facilitating rapid dissolution and absorption of ibuprofen.
- Ensuring capsule integrity during storage and handling.
- Stabilizing the active through moisture control.
- Masking unpleasant taste associated with ibuprofen.
The choice of excipients aligns with FDA and international regulations regarding safety and efficacy for OTC analgesics.
What are potential areas for excipient optimization?
Advances in pharmaceutical excipient technology open opportunities for:
- Enhanced bioavailability: Using newer solubilizers or nanoparticle technology to improve absorption at lower doses.
- Taste masking improvements: Incorporating flavoring agents or novel film-coating techniques for better consumer compliance.
- Reduced excipient load: Moving toward excipient-free or minimal excipient formulations to serve sensitive populations.
- Stability extension: Developing excipients that prolong shelf-life and reduce degradation under varying environmental conditions.
What are commercial opportunities based on excipient innovation?
Developing next-generation LiquiGel formulations offers competitive advantages:
- Differentiation: Improved bioavailability and faster onset can justify premium pricing.
- Market expansion: Formulations tailored for pediatric, geriatric, or sensitive populations with minimal excipients.
- Regulatory positioning: Using excipients recognized as safe (GRAS) by FDA expedites approval processes.
- Shelf-life extension: Longer stability reduces inventory costs and enhances supply chain flexibility.
- Consumer demand: Growing preference for clean-label, minimal-excipient products supports innovation.
Partnering with excipient suppliers who develop novel, safe, and effective excipients can unlock new formulations that meet evolving market needs.
How do competitive strategies align with excipient selection?
- Companies investing in proprietary excipient technology or formulation patents can secure market share.
- Collaboration with excipient manufacturers enables customization, differentiating products.
- Intellectual property around specific excipient combinations can extend product exclusivity.
- Emphasizing safety profiles and minimal excipient content appeals to health-conscious consumers.
Regulatory considerations impacting excipient strategies
Global regulatory agencies like the FDA and EMA require comprehensive safety data on excipients, especially for pediatric or sensitive populations. Labeling must detail excipient content, and certain excipients may restrict use in specific demographics.
Formulations should prioritize excipients with well-established safety profiles. Incorporating excipients with a history of safe use facilitates faster approvals and broadens market access.
Summary of the excipient landscape
| Aspect |
Details |
| Primary excipients |
PEG 400, gelatin, glycerin, propylene glycol, water |
| Recent trends |
Minimal excipient formulations, improved taste masking, enhanced bioavailability |
| Opportunities |
Formulation innovation, stability extension, targeted formulations for sensitive groups |
Key Takeaways
- ADVIL LIQUIGELS rely on excipients that promote rapid absorption, stability, and consumer acceptance.
- Excipient innovations, such as improved solubilizers and taste-masking agents, can enhance product performance.
- Commercial opportunities exist through formulation differentiation, premium pricing, and targeting niche markets.
- Regulatory pathways favor excipients with established safety profiles, facilitating faster approval and broader access.
- Strategic partnerships with excipient suppliers can foster innovation and protect market share.
FAQs
1. What are the main excipients used in ADVIL LIQUIGELS?
The primary excipients include polyethylene glycol 400, gelatin, glycerin, propylene glycol, and water.
2. How can excipient innovation improve ADVIL LIQUIGELS?
Innovations can increase absorption efficiency, improve taste, extend shelf life, and enable formulation for sensitive populations.
3. Are there regulatory hurdles for excipient changes in OTC formulations?
Yes. Changes require safety data submission and may need new stability and bioavailability studies, especially for vulnerable groups.
4. What market segments could benefit from minimal-excipient formulations?
Pediatric, geriatrics, and sensitive individuals benefit most, fostering niche product development.
5. How do excipients impact the commercial success of OTC LiquiGel products?
Excipients influence product efficacy, safety, taste, and stability, directly affecting consumer satisfaction, market differentiation, and regulatory approval.
References
- U.S. Food and Drug Administration. (2020). Inactive Ingredient Database. Retrieved from https://www.fda.gov/
- Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (2009). Handbook of pharmaceutical excipients. Pharmaceutical Press.
- European Medicines Agency. (2019). Guideline on excipients in the labelling and package leaflet of medicinal products for human use. EMA/CHMP/QWP/545525/2017.
